Are Newborn Outcomes Different for Term Babies Who Were Exposed to Antenatal Corticosteroids?. Issue 5 (May 2022)

• Record Type: Journal Article
• Authors: McKinzie, Alexandra H.; Yang, Ziyi; Teal, Evgenia; Daggy, Joanne K.; Tepper, Robert S.; Quinney, Sara K.; Rhoads, Eli; Haneline, Laura S.; Haas, David M.
• Is Part Of: Obstetrical & gynecological survey. Volume 77:Issue 5(2022)
• Page Start: 251
• Page End: 252
• Publication Date: 2022-05
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Surgery -- Periodicals; 618
• DOI: 10.1097/01.ogx.0000831480.18164.54
• Languages: English
• ISSNs: 0029-7828

Abstract

Abstract : (Abstracted from Am J Obstet Gynecol 2021;225:536.e1–536.e7) The administration of antenatal corticosteroids can improve newborn lung function following antenatal treatment of pregnant women who are between 24 and 36 + 6/7 weeks' gestation and at risk of preterm delivery within 7 days. Antenatal corticosteroids, such as betamethasone (BMZ), reduce the risks of respiratory distress syndrome, the need for respiratory support, and admission to the neonatal intensive care unit (NICU).